Stephane Bancel's most recent trade in Moderna Inc was a trade of 499,246 Common Stock done at an average price of $19.2 . Disclosure was reported to the exchange on Aug. 5, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.15 per share. | 05 Aug 2026 | 499,246 | 6,687,037 (1%) | 0% | 19.2 | 9,560,561 | Common Stock |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | 05 Aug 2026 | 370,853 | 187,541 | - | - | Stock Option (Right to Buy) | ||
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.15 per share. | 05 Aug 2026 | 252,469 | 6,440,260 (1%) | 0% | 19.1 | 4,834,781 | Common Stock |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | 05 Aug 2026 | 187,541 | 0 | - | - | Stock Option (Right to Buy) | ||
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 58.79 per share. | 05 Aug 2026 | 187,044 | 6,187,791 (1%) | 0% | 58.8 | 10,996,317 | Common Stock |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 56.21 per share. | 05 Aug 2026 | 147,473 | 6,539,564 (1%) | 0% | 56.2 | 8,289,457 | Common Stock |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | 05 Aug 2026 | 128,393 | 64,928 | - | - | Stock Option (Right to Buy) | ||
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 56.96 per share. | 05 Aug 2026 | 124,838 | 6,414,726 (1%) | 0% | 57.0 | 7,110,772 | Common Stock |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | 05 Aug 2026 | 64,928 | 0 | - | - | Stock Option (Right to Buy) | ||
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 58.12 per share. | 05 Aug 2026 | 39,891 | 6,374,835 (1%) | 0% | 58.1 | 2,318,465 | Common Stock |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | 01 Mar 2026 | 250,932 | 250,932 | - | - | Stock Option (Right to Buy) | ||
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2026 | 11,271 | 6,193,241 (1%) | 0% | 0 | Common Stock | |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2026 | 11,271 | 6,193,241 (1%) | 0% | 0 | - | |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.99 per share. | 11 Feb 2026 | 5,450 | 6,187,791 (1%) | 0% | 42.0 | 228,846 | Common Stock |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.99 per share. | 11 Feb 2026 | 5,450 | 6,187,791 (1%) | 0% | 42.0 | 228,846 | - |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | 11 Dec 2025 | 688,073 | 0 | - | - | Stock Option (Right to Buy) | ||
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.90 per share. | 11 Dec 2025 | 688,073 | 6,181,970 (1%) | 0% | 10.9 | 7,499,996 | Common Stock |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 31.04 per share. | 03 Mar 2025 | 102,821 | 9,153,193 (2%) | 0% | 31.0 | 3,191,564 | Common Stock |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 31.53 per share. | 03 Mar 2025 | 57,493 | 9,210,686 (2%) | 0% | 31.5 | 1,812,754 | Common Stock |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | 01 Mar 2025 | 357,065 | 357,065 | - | - | Stock Option (Right to Buy) | ||
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 13,233 | 5,500,297 (1%) | 0% | 0 | Common Stock | |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.93 per share. | 12 Feb 2025 | 6,400 | 5,493,897 (1%) | 0% | 30.9 | 197,952 | Common Stock |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 14 Jun 2024 | 26,840 | 5,487,064 (1%) | 0% | 0 | Common Stock | |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | 27 Feb 2024 | 151,943 | 151,943 | - | - | Stock Option (Right to Buy) | ||
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 56,736 | 5,486,575 (1%) | 0% | 0 | Common Stock | |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 88.88 per share. | 14 Feb 2024 | 26,351 | 5,460,224 (1%) | 0% | 88.9 | 2,342,098 | Common Stock |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 15 Sep 2023 | 17,893 | 5,429,839 (1%) | 0% | 0 | - | |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.99 per share. | 28 Jun 2023 | 27,155 | 5,439,101 (1%) | 0% | 1.0 | 26,883 | Common Stock |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | 28 Jun 2023 | 27,155 | 0 | - | - | Stock Option (Right to Buy) | ||
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 122.01 per share. | 28 Jun 2023 | 13,094 | 5,412,312 (1%) | 0% | 122.0 | 1,597,599 | Common Stock |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 121.40 per share. | 28 Jun 2023 | 11,417 | 5,425,406 (1%) | 0% | 121.4 | 1,386,024 | Common Stock |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 120.39 per share. | 28 Jun 2023 | 2,278 | 5,436,823 (1%) | 0% | 120.4 | 274,248 | Common Stock |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 123.05 per share. | 28 Jun 2023 | 366 | 5,411,946 (1%) | 0% | 123.0 | 45,036 | Common Stock |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | 21 Jun 2023 | 40,000 | 27,155 | - | - | Stock Option (Right to Buy) | ||
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | 21 Jun 2023 | 40,000 | 67,155 | - | - | Stock Option (Right to Buy) | ||
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.99 per share. | 21 Jun 2023 | 40,000 | 5,451,946 (1%) | 0% | 1.0 | 39,600 | Common Stock |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.99 per share. | 21 Jun 2023 | 40,000 | 5,451,946 (1%) | 0% | 1.0 | 39,600 | Common Stock |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 119.13 per share. | 21 Jun 2023 | 24,829 | 5,427,117 (1%) | 0% | 119.1 | 2,957,879 | Common Stock |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 121.77 per share. | 21 Jun 2023 | 20,711 | 5,431,235 (1%) | 0% | 121.8 | 2,521,978 | Common Stock |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 122.21 per share. | 21 Jun 2023 | 19,289 | 5,411,946 (1%) | 0% | 122.2 | 2,357,309 | Common Stock |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 119.87 per share. | 21 Jun 2023 | 15,171 | 5,411,946 (1%) | 0% | 119.9 | 1,818,548 | Common Stock |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.99 per share. | 14 Jun 2023 | 40,000 | 5,451,946 (1%) | 0% | 1.0 | 39,600 | Common Stock |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | 14 Jun 2023 | 40,000 | 107,155 | - | - | Stock Option (Right to Buy) | ||
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | 14 Jun 2023 | 40,000 | 147,155 | - | - | Stock Option (Right to Buy) | ||
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.99 per share. | 14 Jun 2023 | 40,000 | 5,451,946 (1%) | 0% | 1.0 | 39,600 | Common Stock |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 126.10 per share. | 14 Jun 2023 | 20,848 | 5,420,456 (1%) | 0% | 126.1 | 2,628,933 | Common Stock |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 129.77 per share. | 14 Jun 2023 | 14,277 | 5,411,946 (1%) | 0% | 129.8 | 1,852,726 | Common Stock |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 125.32 per share. | 14 Jun 2023 | 10,642 | 5,441,304 (1%) | 0% | 125.3 | 1,333,655 | Common Stock |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 127.25 per share. | 14 Jun 2023 | 8,510 | 5,411,946 (1%) | 0% | 127.3 | 1,082,898 | Common Stock |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 127.99 per share. | 14 Jun 2023 | 8,443 | 5,433,338 (1%) | 0% | 128.0 | 1,080,620 | Common Stock |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 129.12 per share. | 14 Jun 2023 | 7,115 | 5,426,223 (1%) | 0% | 129.1 | 918,689 | Common Stock |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 127.01 per share. | 14 Jun 2023 | 5,377 | 5,441,781 (1%) | 0% | 127.0 | 682,933 | Common Stock |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 125.61 per share. | 14 Jun 2023 | 4,788 | 5,447,158 (1%) | 0% | 125.6 | 601,421 | Common Stock |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | 07 Jun 2023 | 40,000 | 187,155 | - | - | Stock Option (Right to Buy) | ||
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | 07 Jun 2023 | 40,000 | 227,155 | - | - | Stock Option (Right to Buy) | ||
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.99 per share. | 07 Jun 2023 | 40,000 | 5,451,946 (1%) | 0% | 1.0 | 39,600 | Common Stock |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.99 per share. | 07 Jun 2023 | 40,000 | 5,451,946 (1%) | 0% | 1.0 | 39,600 | Common Stock |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 125.73 per share. | 07 Jun 2023 | 35,872 | 5,416,074 (1%) | 0% | 125.7 | 4,510,187 | Common Stock |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 123.58 per share. | 07 Jun 2023 | 22,215 | 5,429,731 (1%) | 0% | 123.6 | 2,745,330 | Common Stock |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 124.53 per share. | 07 Jun 2023 | 17,396 | 5,412,335 (1%) | 0% | 124.5 | 2,166,324 | Common Stock |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 126.51 per share. | 07 Jun 2023 | 4,128 | 5,411,946 (1%) | 0% | 126.5 | 522,233 | Common Stock |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 125.22 per share. | 07 Jun 2023 | 389 | 5,411,946 (1%) | 0% | 125.2 | 48,711 | Common Stock |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.99 per share. | 31 May 2023 | 40,000 | 5,451,946 (1%) | 0% | 1.0 | 39,600 | Common Stock |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | 31 May 2023 | 40,000 | 267,155 | - | - | Stock Option (Right to Buy) | ||
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | 31 May 2023 | 40,000 | 307,155 | - | - | Stock Option (Right to Buy) | ||
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.99 per share. | 31 May 2023 | 40,000 | 5,451,946 (1%) | 0% | 1.0 | 39,600 | Common Stock |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 128.18 per share. | 31 May 2023 | 29,979 | 5,411,946 (1%) | 0% | 128.2 | 3,842,708 | Common Stock |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 126.71 per share. | 31 May 2023 | 14,636 | 5,427,832 (1%) | 0% | 126.7 | 1,854,528 | Common Stock |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 127.84 per share. | 31 May 2023 | 11,036 | 5,416,796 (1%) | 0% | 127.8 | 1,410,842 | Common Stock |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 125.38 per share. | 31 May 2023 | 9,478 | 5,442,468 (1%) | 0% | 125.4 | 1,188,352 | Common Stock |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 127.53 per share. | 31 May 2023 | 8,611 | 5,441,925 (1%) | 0% | 127.5 | 1,098,161 | Common Stock |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 128.42 per share. | 31 May 2023 | 4,850 | 5,411,946 (1%) | 0% | 128.4 | 622,837 | Common Stock |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 125.96 per share. | 31 May 2023 | 1,410 | 5,450,536 (1%) | 0% | 126.0 | 177,604 | Common Stock |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | 24 May 2023 | 40,000 | 347,155 | - | - | Stock Option (Right to Buy) | ||
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | 24 May 2023 | 40,000 | 387,155 | - | - | Stock Option (Right to Buy) | ||
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.99 per share. | 24 May 2023 | 40,000 | 5,451,946 (1%) | 0% | 1.0 | 39,600 | Common Stock |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.99 per share. | 24 May 2023 | 40,000 | 5,451,946 (1%) | 0% | 1.0 | 39,600 | Common Stock |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 131.13 per share. | 24 May 2023 | 28,144 | 5,423,802 (1%) | 0% | 131.1 | 3,690,523 | Common Stock |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 127.45 per share. | 24 May 2023 | 20,641 | 5,420,938 (1%) | 0% | 127.4 | 2,630,695 | Common Stock |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 126.32 per share. | 24 May 2023 | 10,367 | 5,441,579 (1%) | 0% | 126.3 | 1,309,559 | Common Stock |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 131.98 per share. | 24 May 2023 | 9,820 | 5,413,982 (1%) | 0% | 132.0 | 1,296,044 | Common Stock |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 128.33 per share. | 24 May 2023 | 8,654 | 5,412,284 (1%) | 0% | 128.3 | 1,110,568 | Common Stock |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 132.93 per share. | 24 May 2023 | 2,036 | 5,411,946 (1%) | 0% | 132.9 | 270,645 | Common Stock |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 128.99 per share. | 24 May 2023 | 338 | 5,411,946 (1%) | 0% | 129.0 | 43,599 | Common Stock |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | 17 May 2023 | 40,000 | 427,155 | - | - | Stock Option (Right to Buy) | ||
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | 17 May 2023 | 40,000 | 467,155 | - | - | Stock Option (Right to Buy) | ||
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.99 per share. | 17 May 2023 | 40,000 | 5,451,946 (1%) | 0% | 1.0 | 39,600 | Common Stock |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.99 per share. | 17 May 2023 | 40,000 | 5,451,946 (1%) | 0% | 1.0 | 39,600 | Common Stock |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 123.53 per share. | 17 May 2023 | 28,476 | 5,423,470 (1%) | 0% | 123.5 | 3,517,640 | Common Stock |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 126.17 per share. | 17 May 2023 | 16,248 | 5,412,468 (1%) | 0% | 126.2 | 2,050,010 | Common Stock |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 125.34 per share. | 17 May 2023 | 11,547 | 5,428,716 (1%) | 0% | 125.3 | 1,447,301 | Common Stock |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 124.31 per share. | 17 May 2023 | 10,653 | 5,412,817 (1%) | 0% | 124.3 | 1,324,274 | Common Stock |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 124.24 per share. | 17 May 2023 | 9,350 | 5,440,263 (1%) | 0% | 124.2 | 1,161,644 | Common Stock |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 123.22 per share. | 17 May 2023 | 2,333 | 5,449,613 (1%) | 0% | 123.2 | 287,472 | Common Stock |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 125.24 per share. | 17 May 2023 | 871 | 5,411,946 (1%) | 0% | 125.2 | 109,084 | Common Stock |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 126.86 per share. | 17 May 2023 | 522 | 5,411,946 (1%) | 0% | 126.9 | 66,221 | Common Stock |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.99 per share. | 10 May 2023 | 40,000 | 5,451,946 (1%) | 0% | 1.0 | 39,600 | Common Stock |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | 10 May 2023 | 40,000 | 507,155 | - | - | Stock Option (Right to Buy) | ||
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | 10 May 2023 | 40,000 | 547,155 | - | - | Stock Option (Right to Buy) | ||
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.99 per share. | 10 May 2023 | 40,000 | 5,451,946 (1%) | 0% | 1.0 | 39,600 | Common Stock |
| Moderna | Mr. Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 127.17 per share. | 10 May 2023 | 35,330 | 5,416,616 (1%) | 0% | 127.2 | 4,492,916 | Common Stock |